Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limitedverified

TLX

Price:

$9.78

Market Cap:

$5.01B

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company offers Illuccix for the treatment of prostate cancer; and TLX66-CDx for the treatment of imaging osteomyelitis. Its products candidates include TLX591, a radio antibody-drug conjugate for the treatment of prostate cancer; TLX250-CDx for the treatment and diagnosis of renal (kidney) cancer; TLX101-CDx for brain (glioma) cancer; TLX66-CDx to treat bone marrow conditioning; TLX300-CDx for the treatment and diagnosis...[Read more]

Industry

Biotechnology

IPO Date

2024-11-14

Stock Exchange

NASDAQ

Ticker

TLX

The PE Ratio as of December 2025 (TTM) for Telix Pharmaceuticals Limited (TLX) is 489.00

According to Telix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is 489.00. This represents a change of -1289.45% compared to the average of -41.11 of the last 4 quarters.

Telix Pharmaceuticals Limited (TLX) Historical PE Ratio (quarterly & annually)

How has TLX PE Ratio performed in the past?

The mean historical PE Ratio of Telix Pharmaceuticals Limited over the last ten years is -205.13. The current 489.00 PE Ratio has changed -23938.18% with respect to the historical average. Over the past ten years (40 quarters), TLX's PE Ratio was at its highest in in the June 2024 quarter at 129.41. The PE Ratio was at its lowest in in the June 2025 quarter at -388.92.

Quarterly (TTM)
Annual

Average

-205.13

Median

-17.36

Minimum

-2239.89

Maximum

617.41

Telix Pharmaceuticals Limited (TLX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Telix Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 711.45%

Maximum Annual PE Ratio = 617.41

Minimum Annual Increase = -2945.39%

Minimum Annual PE Ratio = -2239.89

Quarterly (TTM)
Annual
YearPE RatioChange
2024163.29-73.55%
2023617.41-2945.39%
2022-21.70-20.12%
2021-27.1725.39%
2020-21.6766.86%
2019-12.9836.68%
2018-9.50-27.18%
2017-13.05-99.42%
2016-2239.89360.80%
2015-486.09711.45%

Telix Pharmaceuticals Limited (TLX) Average PE Ratio

How has TLX PE Ratio performed in the past?

The current PE Ratio of Telix Pharmaceuticals Limited (TLX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

253.00

5-year avg

142.04

10-year avg

-205.13

Telix Pharmaceuticals Limited (TLX) PE Ratio vs. Peers

How is TLX’s PE Ratio compared to its peers?

Telix Pharmaceuticals Limited’s PE Ratio is greater than Mirum Pharmaceuticals, Inc. (-87.44), greater than Soleno Therapeutics, Inc. (-35.81), greater than Dyne Therapeutics, Inc. (-5.70), greater than ADMA Biologics, Inc. (23.24), greater than Belite Bio, Inc (-99.83), greater than Ligand Pharmaceuticals Incorporated (101.89), greater than ACADIA Pharmaceuticals Inc. (20.06), greater than Ultragenyx Pharmaceutical Inc. (-6.29), greater than Celcuity Inc. (-29.14), greater than Praxis Precision Medicines, Inc. (-16.25),

Build a custom stock screener for Telix Pharmaceuticals Limited (TLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Telix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Telix Pharmaceuticals Limited (TLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Telix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Telix Pharmaceuticals Limited's PE Ratio?

How is the PE Ratio calculated for Telix Pharmaceuticals Limited (TLX)?

What is the highest PE Ratio for Telix Pharmaceuticals Limited (TLX)?

What is the 3-year average PE Ratio for Telix Pharmaceuticals Limited (TLX)?

What is the 5-year average PE Ratio for Telix Pharmaceuticals Limited (TLX)?

How does the current PE Ratio for Telix Pharmaceuticals Limited (TLX) compare to its historical average?